CVOct 27, 2022

Multi-view Contrastive Learning with Additive Margin for Adaptive Nasopharyngeal Carcinoma Radiotherapy Prediction

arXiv:2210.15201v17 citationsh-index: 16
Originality Incremental advance
AI Analysis

This work addresses a domain-specific medical imaging problem for nasopharyngeal carcinoma patients, with incremental improvements in loss function design.

The paper tackled the problem of predicting adaptive radiation therapy for nasopharyngeal carcinoma patients by proposing a supervised multi-view contrastive learning method with an additive margin, which enhanced image representation and improved discrimination in the embedding space.

The prediction of adaptive radiation therapy (ART) prior to radiation therapy (RT) for nasopharyngeal carcinoma (NPC) patients is important to reduce toxicity and prolong the survival of patients. Currently, due to the complex tumor micro-environment, a single type of high-resolution image can provide only limited information. Meanwhile, the traditional softmax-based loss is insufficient for quantifying the discriminative power of a model. To overcome these challenges, we propose a supervised multi-view contrastive learning method with an additive margin (MMCon). For each patient, four medical images are considered to form multi-view positive pairs, which can provide additional information and enhance the representation of medical images. In addition, the embedding space is learned by means of contrastive learning. NPC samples from the same patient or with similar labels will remain close in the embedding space, while NPC samples with different labels will be far apart. To improve the discriminative ability of the loss function, we incorporate a margin into the contrastive learning. Experimental result show this new learning objective can be used to find an embedding space that exhibits superior discrimination ability for NPC images.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes